Mitochondrial alterations in nonalcoholic fatty liver disease. Pediatric case description of three submitted sequential biopsies

Journal of Gastrointestinal and Liver Diseases

Volumn 18, Issue 2, 2009, Pages 215-219

  Da Silva, Gustavo Henrique ^a   Coelho, Kunie Iabuki Rabello ^b   Coelho, Cláudio Antônio Rabello ^b   Escanhoela, Cecilia Amélia Fazzio ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Liver; Microvesicular steatosis; Mitochondrial alterations; NAFLD

Indexed keywords

ARTICLE; CASE REPORT; CHILD; DISEASE COURSE; ECHOGRAPHY; HEPATOMEGALY; HISTOPATHOLOGY; HUMAN; LIPID STORAGE; LIVER BIOPSY; LIVER CELL; LIVER FIBROSIS; MITOCHONDRIAL VOLUME DENSITY; MORPHOMETRICS; NONALCOHOLIC FATTY LIVER; PERCUTANEOUS BIOPSY; STAINING; TRANSMISSION ELECTRON MICROSCOPY; BIOPSY; FATTY LIVER; HYPERTROPHY; INFANT; LIVER MITOCHONDRION; MITOCHONDRIAL VOLUME; PATHOLOGY;

BIOPSY; FATTY LIVER; HEPATOMEGALY; HUMANS; HYPERTROPHY; INFANT; MITOCHONDRIA, LIVER; MITOCHONDRIAL SIZE;

EID: 70149125292     PISSN: 18418724     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Browning JD, Horton JD. Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 2004; 114: 147-152. (Pubitemid 39071617)
2. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 2003; 37: 1202-1219.
3. Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006; 43: S99-S112. (Pubitemid 43303974)
4. Moran JR, Ghishan FK, Halter SA, Greene HL. Steatohepatitis in obese children: a cause of chronic liver dysfunction. Am J Gastroenterol 1983; 78: 374-377.
5. Marion AW, Baker AJ, Dhawan A. Fatty liver disease in children. Arch Dis Child 2004; 89: 648-652.
6. Pessayre D, Mansouri A, Haouzi D, Fromenty B. Hepatotoxicity due to mitochondrial dysfunction. Cell Biol Toxicol 1999; 15: 367-373.
7. Rashid M, Roberts EA. Nonalcoholic steatohepatitis in children. J Pediatr Gastroenterol Nutr 2000; 30: 48-53.
8. Molleston JP, White F, Teckmann J, Fitzgerald JF. Obese children with steatohepatitis can develop cirrhosis in childhood. Am J Gastroenterol 2002; 97: 2460-2462. (Pubitemid 35052071)
9. Mandel H, Hartman C, Berkowitz D, Elpeleg ON, Manov I, Iancu TC. The hepatic mitochondrial DNA depletion syndrome: ultrastructural changes in liver biopsies. Hepatology 2001; 34: 776-784. (Pubitemid 32928003)
10. Bioulac -Sage P, Parrot-Roulaud F, Mazat JP, et al. Fatal neonatal liver failure and mitochondrial cytopathy (oxidative phosphorylation defi ciency): a light and electron microscopic study of the liver. Hepatology 1993; 18: 839-846.
11. th ed. Boston: Butterworth-Heinemann, 1997: 266-272.
12. Perez-Carreras M, Del Hoyo P, Martin MA, et al. Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis. Hepatology 2003; 38: 999-1007. (Pubitemid 37221683)
13. Morris AA. Mitochondrial respiratory chain disorders and the liver. Liver 1999; 19: 357-368. (Pubitemid 29457212)
14. Hensley K, Kotake Y, Sang H, et al. Dietary choline restriction causes complex I dysfunction and increased H(2)O(2) generation in liver mitochondria. Carcinogenesis 2000; 21: 983-989.
15. Harrison SA, Di Bisceglie AM. Advances in the understanding and treatment of nonalcoholic fatty liver disease. Drugs 2003; 63: 2379-2394. (Pubitemid 37392905)
16. Zamin JI, Mattos AA, Perin C, Ramos GZ. The importance of AST / ALT rate in nonalcoholic steatohepatitis diagnosis. Arq Gastroenterol 2002; 39: 22-26.
17. th ed. Oxford: Blackwell Science, 2002: 423-452.
18. Sokol RJ, Treem WR. Mitochondria and childhood liver diseases. J Pediatr Gastroenterol Nutr 1999; 28: 4-16.
19. Naviaux RK, Nyhan WL, Barshop BA, et al. Mitochondrial DNA polymerase gamma defi ciency and mtDNA depletion in a child with Alpers' syndrome. Ann Neurol 1999; 45: 54-58.
20. Boustany RN, Aprille JR, Halperin J, Levy H, DeLong GR. Mitochondrial cytochrome defi ciency presenting as myopathy with hypotonia, external ophthalmoplegia, and lactic acidosis in an infant and as fatal hepatopathy in a second cousin. Ann Neurol 1983; 14: 462-470.
21. Fromenty B, Pessayre D. Inhibition of mitocondrial beta-oxidation as a mechanism of hepatotoxicity. Pharmacol Ther 1995; 67: 101-154.
22. Jolly RA, Ciurlionis R, Morfi tt D, et al. Microvesicular steatosis induced by a short chain fatty acid: effects on mitochondrial function and correlation with gene expression. Toxicol Pathol 2004; 32 Suppl 2:19-25.
23. Rehnmark S, Giometti CS, Slavin GB, Doolittle MH, Reue K. The fatty liver dystrophy mutant mouse: microvesicular steatosis associated with altered expression levels of peroxisome proliferator regulated proteins. J Lipid Res 1998; 39: 2209-2217.
24. Zimmerman JH. Hepatotoxicity: the adverse effects of drugs and other chemicals on the liver. 2nd ed. New York: Appleton-Century- Crofts, 1999: 789.
25. Natarajan SK, Eapen CE, Pullimood AB, Balasubramanian KA. Oxidative stress in experimental liver microvesicular steatosis: role of mitochondria and peroxisomes. J Gastroenterol Hepatology 2006; 21: 1240-1249.
26. Treem WR, Sokol RJ. Disorders of the mitochondria. Semin Liver Dis 1998; 18: 237-253.